STOCK TITAN

2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual)

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

GREENWICH, Conn.--()--Join us as we discuss today’s pressing healthcare issues.

CO-HOSTS:

Bunny Ellerin Jing He
Director, HPM, Columbia Business School Biotech Analyst, Gabelli Funds
  • MBA, Harvard Business School
  • MBA, Columbia Business School
  • BA, Columbia University
  • MA, Washington University in St. Louis
  • BS, Peking University
Time Agenda
9:00 – 9:10 AM Welcome
  • Bunny Ellerin, Director, Healthcare and Pharmaceutical Management Program
9:10 – 10:00 AM Vaccines & Therapeutics to Treat COVID-19
  • David Hering, Regional President, North America, Pfizer Vaccines
  • Dr. Jacqueline Miller, Senior Vice President, Infectious Diseases, Moderna
  • Dr. David Weinreich, Senior Vice President, Global Clinical Development, Regeneron
  • (Moderator) Jing He ‘15, Biotech Analyst, Gabelli Funds
10:10 – 11:00 AM Health Policy & Reimbursement Trends
  • Dr. Deepa Kumaraiah, Senior Vice President, Service Lines and Chief Physician, NYP Medical Groups, New York-Presbyterian
  • Melissa Schulman, Senior Vice President of Government Affairs, CVS Health
  • Professor Michael Sparer, Chair, Health Policy and Management, Columbia University Mailman School of Public Health
  • (Moderator) Jeff Jonas, Portfolio Manager, Gabelli Funds
11:10 – Noon Healthcare Delivery in a Virtual World
  • Dr. Amy Fahrenkopf, President, HSS Health and Senior Vice President, Hospital for Special Surgery
  • Jason Gorevic, CEO, Teladoc Health
  • Dr. Julie Silverstein, Divisional President, Oak Street Health
  • (Moderator) Kevin Kedra, Healthcare Analyst, G.research

Click Here to Register

Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and is a wholly owned subsidiary of GAMCO Investors, Inc. (NYSE: GBL).

Contacts

Douglas R. Jamieson
914-921-5020
djamieson@gabelli.com

GBL

NYSE:GBL

GBL Rankings

GBL Latest News

GBL Stock Data

389.63M
4.97M
4.23%
74.61%
0.25%
Securities and Commodity Exchanges
Finance and Insurance
Link
United States
Rye

About GBL

GAMCO is known for its research-driven approach to equity investing. GAMCO conducts its investment advisory business principally through two subsidiaries: GAMCO Asset Management Inc. (approximately 1,500 institutional and private wealth separate accounts, principally in the U.S.) and Gabelli Funds, LLC (24 open-end funds, a SICAV, and 16 closed-end funds). GAMCO serves a broad client base including institutions, intermediaries, offshore investors, private wealth, and direct retail investors. GAMCO offers a wide range of solutions across Value and Growth Equity, ESG-SRI, Convertibles, sector- focused strategies including Gold and Utilities, Merger Arbitrage, and Fixed Income. In 1977, GAMCO launched its flagship All Cap Value strategy, Gabelli Value, and in 1986 launched its mutual fund business. In addition to its Value strategies, for over 30 years the firm has managed solutions in Growth and Global Growth Equity, Convertibles, SRI, and Merger Arbitrage.